Harim Koo

658 total citations
14 papers, 124 citations indexed

About

Harim Koo is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Harim Koo has authored 14 papers receiving a total of 124 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Harim Koo's work include Glioma Diagnosis and Treatment (10 papers), Cancer Genomics and Diagnostics (4 papers) and Ferroptosis and cancer prognosis (4 papers). Harim Koo is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Cancer Genomics and Diagnostics (4 papers) and Ferroptosis and cancer prognosis (4 papers). Harim Koo collaborates with scholars based in South Korea, United States and Japan. Harim Koo's co-authors include K. Jason, Do‐Hyun Nam, Hee Jin Cho, Seung Won Choi, Doo‐Sik Kong, Ho Jun Seol, Donggeon Kim, Do‐Hyun Nam, Bernhard Baumann and Hye Won Lee and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and International Journal of Molecular Sciences.

In The Last Decade

Harim Koo

13 papers receiving 124 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harim Koo South Korea 7 52 46 36 34 27 14 124
Alicia Steffens United States 4 81 1.6× 34 0.7× 34 0.9× 25 0.7× 22 0.8× 10 136
Yunbo Zhan China 7 50 1.0× 53 1.2× 31 0.9× 30 0.9× 20 0.7× 9 135
Taishi Nakamura Japan 6 126 2.4× 51 1.1× 45 1.3× 21 0.6× 30 1.1× 21 177
Daniel I. Jacobs United States 6 80 1.5× 117 2.5× 65 1.8× 38 1.1× 33 1.2× 8 226
S. C. Erridge United Kingdom 4 109 2.1× 41 0.9× 33 0.9× 16 0.5× 53 2.0× 5 129
Kristyn Galbraith United States 6 125 2.4× 88 1.9× 69 1.9× 22 0.6× 48 1.8× 21 190
Macarena I. de la Fuente United States 8 122 2.3× 34 0.7× 23 0.6× 28 0.8× 32 1.2× 13 180
Liana Nobre Canada 8 110 2.1× 45 1.0× 16 0.4× 23 0.7× 32 1.2× 30 149
Yosuke Kitagawa Japan 7 74 1.4× 32 0.7× 19 0.5× 51 1.5× 30 1.1× 19 142
Jiangfen Zhou China 6 46 0.9× 56 1.2× 38 1.1× 19 0.6× 45 1.7× 18 127

Countries citing papers authored by Harim Koo

Since Specialization
Citations

This map shows the geographic impact of Harim Koo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harim Koo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harim Koo more than expected).

Fields of papers citing papers by Harim Koo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harim Koo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harim Koo. The network helps show where Harim Koo may publish in the future.

Co-authorship network of co-authors of Harim Koo

This figure shows the co-authorship network connecting the top 25 collaborators of Harim Koo. A scholar is included among the top collaborators of Harim Koo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harim Koo. Harim Koo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Koo, Harim & K. Jason. (2025). Proteogenomic Insights Into Glioblastoma Evolution: Neuronal Reprogramming and Therapeutic Vulnerabilities. Brain Tumor Research and Treatment. 13(3). 81–81. 1 indexed citations
2.
Lee, Eun Jung, Jiwon Kim, You-Jin Song, et al.. (2025). Single-cell analysis reveals a longitudinal trajectory of meningioma evolution and heterogeneity. Nature Communications. 16(1). 5481–5481. 1 indexed citations
3.
Kim, Chang Gon, Harim Koo, Woo Sun Kwon, et al.. (2025). Use of integrated multi-omics profiling in renal cell carcinoma to identify molecular subtypes and associated clinical outcomes and therapeutic vulnerabilities.. Journal of Clinical Oncology. 43(5_suppl). 588–588. 1 indexed citations
4.
Jang, Byunghyun, et al.. (2024). Integrative multi-omics characterization reveals sex differences in glioblastoma. Biology of Sex Differences. 15(1). 23–23. 13 indexed citations
5.
6.
Choi, Seung Won, Yeri Lee, Harim Koo, et al.. (2021). Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma. Cell Death and Disease. 12(4). 374–374. 23 indexed citations
7.
Koo, Harim, Seung Won Choi, Hee Jin Cho, et al.. (2020). Ethnic delineation of primary glioblastoma genome. Cancer Medicine. 9(19). 7352–7359. 6 indexed citations
8.
Choi, Seung Won, Hwan-ho Cho, Harim Koo, et al.. (2020). Multi-Habitat Radiomics Unravels Distinct Phenotypic Subtypes of Glioblastoma with Clinical and Genomic Significance. Cancers. 12(7). 1707–1707. 30 indexed citations
9.
Lee, Kyoungmin, Harim Koo, Yejin Kim, et al.. (2020). Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts. Cancers. 12(11). 3210–3210. 10 indexed citations
10.
Cho, Hee Jin, Hyunju Kang, Jin‐Ku Lee, et al.. (2020). Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening. Cancers. 12(3). 549–549. 2 indexed citations
11.
Yun, Jae Won, Harim Koo, Hee‐Jin Kim, et al.. (2019). Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 Fusion. International Journal of Molecular Sciences. 20(7). 1717–1717. 8 indexed citations
12.
Lee, Mijeong, Yeon-Soo Kim, Kyoungmin Lee, et al.. (2019). Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models. Cancers. 11(8). 1090–1090. 6 indexed citations
13.
Jason, K., Jin‐Ku Lee, Hee Jin Cho, et al.. (2018). Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma. Neuro-Oncology. 21(2). 222–233. 14 indexed citations
14.
Choi, Seung Won, K. Jason, Hee Jin Cho, et al.. (2018). Identification of transcriptome signature for predicting clinical response to bevacizumab in recurrent glioblastoma. Cancer Medicine. 7(5). 1774–1783. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alicia Steffens Breakdown of academic impact, for papers by Yunbo Zhan Breakdown of academic impact, for papers by Taishi Nakamura Breakdown of academic impact, for papers by Daniel I. Jacobs Breakdown of academic impact, for papers by S. C. Erridge Breakdown of academic impact, for papers by Kristyn Galbraith Breakdown of academic impact, for papers by Macarena I. de la Fuente Breakdown of academic impact, for papers by Liana Nobre Breakdown of academic impact, for papers by Yosuke Kitagawa Breakdown of academic impact, for papers by Jiangfen Zhou
Rankless by CCL
2026